TGTX TG THERAPEUTICS
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · before market open
What 10 analyst firms say about TG THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
10 rated views · 11 analyst/firm records · 10 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8027
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8034
Recent analyst activity · last 90 days
Our tracked history has 4 reports on TGTX from 4 analyst firms in the last 90 days (10 firms in the past year).
Comparing each firm's latest target with its previous one: 2 left it unchanged and 1 has its first observed target in the past year.
No firm's latest available rating differs from its previous one.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| B Riley Securities | William Wood | Buy | 2 Sep 2026 | 86.00 USD |
| B Riley Securities | William Woods | Buy | 27 Jul 2026 | 86.00 USD |
| Bank of America Securities | Alec Stranahan | Sell | 7 Jul 2026 | 20.00 USD |
| Cantor Fitzgerald | Prakhar Agrawal | Buy | 14 Jan 2026 | — |
| Goldman Sachs | Corinne Johnson | Hold | 16 Apr 2026 | 41.00 USD |
| H.C. Wainwright | Emily Bodnar | Buy | 1 Sep 2026 | 78.00 USD |
| Jefferies | Roger Song | Buy | 22 Jun 2026 | 83.00 USD |
| JPMorgan | Brian Cheng | Buy | 7 Aug 2026 | 72.00 USD |
| TD Cowen | Tara Bancroft | Buy | 21 Jul 2026 | 75.00 USD |
| Weiss Ratings | Unnamed analyst | — | 23 Oct 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 6 Oct 2026 | 59.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 04:06 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.